rs119103262
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_014874.4(MFN2):c.493C>G(p.His165Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H165L) has been classified as Uncertain significance.
Frequency
Consequence
NM_014874.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary motor and sensory, type 6AInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- axonal hereditary motor and sensory neuropathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 2A2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple symmetric lipomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-onset axonal neuropathy due to MFN2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MFN2 | NM_014874.4 | c.493C>G | p.His165Asp | missense_variant | Exon 6 of 19 | ENST00000235329.10 | NP_055689.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MFN2 | ENST00000235329.10 | c.493C>G | p.His165Asp | missense_variant | Exon 6 of 19 | 1 | NM_014874.4 | ENSP00000235329.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2A2 Pathogenic:1
- -
Charcot-Marie-Tooth disease type 2 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.His165 amino acid residue in MFN2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16835246, 16714318, 24819634, 17309650, 24126688, 27549087). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed to segregate with autosomal dominant Charcot-Marie-Tooth disease with pyramidal features in a large family (PMID: 16087932). ClinVar contains an entry for this variant (Variation ID: 2275). This variant is not present in population databases (ExAC no frequency). This sequence change replaces histidine with aspartic acid at codon 165 of the MFN2 protein (p.His165Asp). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and aspartic acid. -
Charcot-Marie-Tooth disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at